Ending HIV Transmission by 2030: Global strategies, prevention tools, and real world challenges

Short summary

In this podcast the Naked Scientists examine how countries are pursuing the UNAIDS 2030 target to end new HIV transmissions. The discussion covers the UK HIV action plan, testing strategies in emergency departments, and the expanding use of PrEP and antiretroviral therapy as prevention. It also brings in international perspectives from Africa and Australia, highlighting the impact of stigma, funding gaps, and the promise of long acting PrEP to accelerate progress.

• UNAIDS 2030 target to halt HIV transmission and the UK policy blueprint to achieve it
• PrEP and ART as core prevention tools, with attention to long acting formulations
• Stigma, testing barriers, and the importance of destigmatizing testing and expanding access
• Global perspectives including Africa's concentrated epidemic and Australia's successful PrEP rollout

Overview

In the podcast, the Naked Scientists explore how countries around the world are adopting strategies to end new HIV infections by 2030. The conversation weaves together policy initiatives, medical interventions, and personal experiences to illustrate the practical path toward reducing new cases while acknowledging substantial challenges. The program emphasizes that while a vaccine remains elusive, advances in treatment and prevention are offering a credible route to turning the HIV pandemic into a manageable public health issue rather than an unstoppable crisis.

UNAIDS goals and the UK response

The episode highlights the UNAIDS aspiration to halt transmission by 2030 and the UK's adoption of this goal through a government HIV action plan that began in 2021 and is being renewed to learn from what has worked so far. The Terrence Higgins Trust and allied organizations formed a commission to turn the aspiration into a blueprint for action, emphasizing testing, access to treatment, and prevention. The UK context is framed by a current landscape of about 106,000 people living with HIV, with approximately 5,000 individuals not yet diagnosed. The priority becomes finding those undiagnosed individuals and linking them to care, using innovations in testing and care pathways.

Testing, linkage to care, and opt out strategies

The podcast discusses testing as a central pillar of ending new transmissions. Innovations include integrating HIV testing into sexual health services and in settings such as accident and emergency departments, obstetric care, and dermatology clinics. The UK has implemented opt out testing in a growing number of sites and aims to broaden testing to ensure no one leaves a service without an HIV test. The conversation also notes that testing outreach and digital confidential testing can reach those hesitant to test due to stigma or fear.

Prevention tools: PrEP, PEP, and condoms

A core theme is the use of Pre-Exposure Prophylaxis (PrEP) to prevent acquisition in at risk individuals, with long acting forms becoming more available and attractive to users who struggle with daily pill adherence. The podcast also explains that treatment for people living with HIV, when viral load is suppressed to undetectable levels, provides a powerful form of prevention. Condoms remain a barrier method for those at risk who test negative. The podcast stresses integration of prevention tools with testing and treatment services to interrupt transmission more effectively.

Global perspectives: Africa and Australia

The discussion moves to Africa where southern Africa bears the largest burden. Slim Abdul Karim describes how age disparities in sex contribute to high transmission rates among young women and outlines the cycle of transmission that sustains the epidemic. Pre exposure prophylaxis is highlighted as a tool to empower women to control their risk, including the potential of injections every six months, which could be highly impactful in reducing transmissions. Conversely, in Australia, Will Tingle talks about the dramatic decline in new HIV cases in inner Sydney following a large scale PrEP rollout and universal healthcare, noting challenges in outer suburbs where access to PrEP can be more difficult and provider knowledge can lag. The conversation also covers circumcision as a protective measure historically, but emphasizes that the most impactful strategies now are combination approaches that include PrEP and treatment as prevention, particularly given the 90 percent reduction in onward transmission when viral load is undetectable.

Barriers, risks, and the path forward

Across regions, debt in funding for PrEP and testing, stigma and discrimination, and concerns about antiretroviral resistance are identified as key barriers. The podcast notes that resistance has occurred in a minority of cases but remains a manageable concern if PrEP and ART are used appropriately and continued monitoring is in place. Pediatric treatment targets in Africa lag behind adults, and vaccination remains unavailable for HIV, underscoring the need for sustained investment and political will. The conversation closes with cautious optimism, recognizing that the tools exist to stop transmission but emphasizing that real progress depends on bridging funding gaps and sustaining political commitment.

Conclusion and outlook

Overall, the podcast argues for a pragmatic, multi‑layered approach to ending new HIV infections by 2030, combining testing, PrEP, ART, and destigmatization with strong policy leadership and international collaboration. The hosts close with a sense of purpose and a call for continued investment and action to translate knowledge into broad impact.